Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MEPI (Maison Européenne des Procédés Innovants) is a French Contract Research and Technology Organization (CRTO) specializing in flow chemistry and process intensification for the pharmaceutical and fine chemical industries. Based in Toulouse, the company provides expertise in transitioning chemical processes from traditional batch reactors to continuous flow systems, utilizing advanced micro-reactor and meso-reactor technologies. MEPI offers a comprehensive suite of services including R&D, process optimization, scale-up, and pilot-scale manufacturing. By focusing on innovative engineering solutions, the company helps its partners improve reaction safety, reduce environmental impact, and enhance production efficiency. MEPI serves as a key bridge between academic research and industrial application in the field of sustainable chemical manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MEPI.